Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $46.54 ($1.9M) on 2019-07-24, disclosed to the SEC on 2019-07-26.
Seasonal sale ($1.9M) by Chief Executive Officer — this insider has traded FGEN in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.54 | 18,400 | $856K | 46.2% |
| 2 | $46.57 | 1,418 | $66K | 3.6% |
| 3 | $46.80 | 1,318 | $62K | 3.3% |
| 4 | $46.86 | 16,500 | $773K | 41.7% |
| 5 | $47.72 | 1,900 | $91K | 4.9% |
| 6 | $47.90 | 100 |
| $5K |
| 0.3% |
| Total | $46.74 avg | 39,636 | $1.9M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-07 | $1.5M | — | Filing → |